Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Resolved | 2019-11-28 | 2020-07-16 | 99916 |
| TEVETEN PLUS | 600MG 12.5MG | TABLET | Avoided shortage | 2020-07-16 | 2020-08-04 | 120414 |
| TEVETEN PLUS | 600MG 12.5MG | TABLET | Avoided shortage | 2020-09-22 | 2020-09-29 | 124719 |
| TEVETEN PLUS | 600MG 12.5MG | TABLET | Resolved | 2020-10-06 | 2020-11-03 | 125760 |
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Resolved | 2022-09-13 | 2024-12-10 | 169169 |
| UROZIDE | Actual shortage | 2017-11-02 | 2018-02-15 | 27905 | ||
| UROZIDE | Actual shortage | 2017-11-02 | 2017-11-02 | 27908 | ||
| UROZIDE | Actual shortage | 2017-11-02 | 2017-11-02 | 27911 | ||
| UROZIDE | Actual shortage | 2017-11-02 | 2017-11-02 | 27914 | ||
| UROZIDE | Actual shortage | 2017-11-02 | 2017-11-02 | 27917 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Discontinued | 2024-12-10 | 2024-12-10 | 245261 |
| VALSARTAN HCT | 25MG 320MG | TABLET | Discontinued | 2019-09-18 | 2020-01-09 | 94211 |